Publications by authors named "Claus Escher"

Claim this Profile
[
[Brain health services: individual dementia risk profiling at the Cologne Alzheimer Prevention Center].
Philip Zeyen, Lena Sannemann, Lara Bohr, Claus Escher, Theresa Müller

Nervenarzt· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Description of a European memory clinic cohort undergoing amyloid-PET: The AMYPAD Diagnostic and Patient Management Study.
Daniele Altomare, Lyduine Collij, Camilla Caprioglio, Philip Scheltens, Bart N M van Berckel, Claus Escher

Alzheimers Dement· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Body Concept and Quality of Life in Patients with Idiopathic Dystonia.
Lejla Paracka, Florian Wegner, Claus Escher, Martin Klietz, Martina de Zwaan

Brain Sci· July 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Stress and Alzheimer's disease.
Claus M Escher, Lena Sannemann, Frank Jessen

J Neural Transm (Vienna)· September 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Prevention of cognitive decline and dementia by treatment of risk factors].
Claus Escher, Frank Jessen

Nervenarzt· September 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Botulinum neurotoxin serotype D - A potential treatment alternative for BoNT/A and B non-responding patients.
Anna Kutschenko, Jasmin Weisemann, Katja Kollewe, Thiemo Fiedler, Sascha Alvermann, Claus Escher

Clin Neurophysiol· June 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Botulinum toxin in the management of chronic migraine: clinical evidence and experience.
Claus M Escher, Lejla Paracka, Dirk Dressler, Katja Kollewe

Ther Adv Neurol Disord· February 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-term treatment of chronic migraine with OnabotulinumtoxinA: efficacy, quality of life and tolerability in a real-life setting.
Katja Kollewe, Claus M Escher, Dirk U Wulff, Davood Fathi, Lejla Paracka

J Neural Transm (Vienna)· May 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis